News

A tough economy is weighing on growth.

An overnight bounce following dovish remarks from the Bank of Japan has failed to hold.

Takeda Pharmaceutical Co Ltd (NYSE:TAK) stock is trading higher on Wednesday. Earlier today, the European Commission approved Takeda’s Adzynma (recombinant ADAMTS13) for treating ADAMTS13 deficiency in children and adult patients with congenital thrombotic thrombocytopenic purpura (cTTP). Congenital thrombotic thrombocytopenic purpura, also known as Upshaw-Schulman syndrome, is a rare inherited disorder that affects the blood’s ability to clot properly. This condition leads to the excessive form

The criminal group used a company that functioned as a crypto exchange.

Bitcoin swooned, and crypto markets followed. Should blockchain-project founders and developers be worried? PLUS: We break down Ronin Network's $12 million run-in with white-h...

(Bloomberg) -- Oil rallied as markets globally recovered from a recent rout and investors remained on edge over the possibility of a retaliatory strike from Iran on Israel.Most Read from BloombergAfrica’s Richest City Needs $12 Billion to Fix InfrastructureNew York City’s Outdoor Dining Sheds Will Start DisappearingThe 5 Coastal States That Face the Most Devastating Flood RiskNew York City Paid $2 Million for Empty Hotel Rooms Meant for MigrantsParis Spent €1.4 Billion to Clean Up the Seine. Has

Investors bought the beaten-down infrastructure stock ahead of earnings.

The latest in blockchain tech upgrades, funding announcements and deals. For the period of Aug. 1-7.